If the claim holds up, personalized phage therapy could become a new frontline weapon against antibiotic resistance - but proof is far from final.

OpenAI's AI proved a weaker version of the biggest open question in math, and human experts have already unpacked it.

A military-backed startup's button-sized device is reshaping at-home hormone testing, and telehealth giants are racing to adopt it.

A decade after Elizabeth Holmes's startup collapsed, a viral documentary has reignited the Theranos story, while researchers remind founders that hype is no substitute for proof.

A barge landing and net-based recovery move China from theory to proof, reshaping the reusability race and satellite ambitions.

A small modular nuclear startup cleared the self-sustaining line. Regulators and investors now shift to the next proof point.